Tag: Infectious Disease
PharmaSignal — Infectious Disease therapeutic area
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
BioPharma Dive
A program that got caught up in HHS decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
Pivotal trial of Moderna’s H5N1 bird flu jab gets underway
Pharmaphorum
The first volunteers in a large-scale trial of Moderna’s mRNA-based vaccine against bird flu have received shots in the UK and US.
MSD secures EC approval for Enflonsia to prevent infant RSV infection
Pharmaceutical Business Review
This approval authorises Enflonsia’s marketing across all 27 European Union member states, Iceland, Liechtenstein and Norway.
Scientists issue call to arms over antifungal resistance
Pharmaphorum
Infectious disease experts from around the world are calling for concerted action to combat a “silent surge” in resistance to antifungal drugs.
Shionogi secures $482m BARDA contract to tackle AMR crisis
Pharmaceutical Technology
Shionogi will use the money from BARDA to build an American antibiotic manufacturing site as the US looks to fight antimicrobial resistance.
EU invests 30m to fight antimicrobial resistance
Pharmaphorum
The EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.
Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment
BioSpace
COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data.
Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
BioPharma Dive
The partners said the shot produced clinically meaningful efficacy despite missing its main study objective, a finding they blamed on a lower-than-expected rate of infections during the trial.